PHARMA TECHNOLOGY A/S: Financial statements 2012
CVR: 20826746
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
PHARMA TECHNOLOGY A/S (CVR 20826746) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 5,987,257 and a net result of DKK 1,428,526. Equity in the 2012 report amounted to DKK 1,928,526. The solvency ratio was 37.9%.
- Gross Profit
- DKK 5,987,257
- Profit/Loss
- DKK 1,428,526
- Equity
- DKK 1,928,526
- Total Assets
- DKK 5,089,613
Keep an eye on PHARMA TECHNOLOGY A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of May 8, 2012, Inge Holsted Hansen has joined the board of directors of PHARMA TECHNOLOGY A/S.
As of May 8, 2012, Bjarne Grølsted-Kristensen has left the board of directors of PHARMA TECHNOLOGY A/S.
About PHARMA TECHNOLOGY A/S
PHARMA TECHNOLOGY A/S is a Danish company of the type Aktieselskab based in Køge, founded in 1998. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Flemming Sten Pedersen. The board consists of Flemming Sten Pedersen, Inge Holsted Hansen and Svenn Ryberg Hansen. The company is owned by FPIH HOLDING ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 48,337,049 and a net result of DKK 12,305,927 compared with DKK 9,046,574 the year before. Equity in the 2025 report amounted to DKK 12,805,927.